emerging

Brain Manipulation Tech

AI-driven advancements in brain-computer interfaces and deep brain stimulation are enabling personalized treatments for neurological disorders.

Detailed Analysis

Brain-computer interfaces (BCIs) are approaching commercialization, initially targeting motor-impaired patients. AI is improving the interpretation of neural signals, enhancing the potential of BCIs and deep brain stimulation for rehabilitation and communication. This is paving the way for a new category of medical and consumer brain manipulation technology, addressing conditions like depression, OCD, and ADHD.

Context Signals

Human trials of BCIs by companies like Neuralink, Synchron, and Paradromics AI-powered personalized algorithms for deep brain stimulation Funding of startups like Motif Neurotech, Forest Neurotech, and Neurode

Edge

Non-invasive brain stimulation devices for cognitive enhancement Personalized brain-computer interfaces for education and training Ethical considerations surrounding brain manipulation technology
Click to access the source report
Tune in
to all the
TRENDS
The stage is set for a massive new category of medical and consumer brain manipulation technology to emerge in the next 10-15 years